Diego Dasilva, MD, FAAD
SESSIONS
F099 JAK Inhibitors in Dermatology: Identifying Ideal Candidates
Mar 30, 2026
•
3:30 PM - 5:30 PM
•
Mile High 2B
DISCLOSURES
AbbVie – Speaker/Faculty Education(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Pharma – Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); UCB – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Speaker(Honoraria);